XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation
 6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation
Note 11. Stock-Based Compensation
The following table summarizes the classification of stock-based compensation expense in the unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Cost of revenue$62 $— $96 $— 
Selling and marketing$496 $710 $799 $1,404 
Product and technology966 1,426 1,658 2,521 
General and administrative6,476 4,969 10,357 8,548 
Total stock-based compensation expense$8,000 $7,105 $12,910 $12,473 

Under our 2020 Stock Incentive Plan, employees, directors and consultants are eligible for grants of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards (“RSAs”), restricted stock units (“RSUs”), performance restricted stock units (“PRSUs”), and other stock awards, collectively referred to as “Equity Awards.” All Equity Awards granted during the six months ended June 30, 2025, were to employees and directors.
The following table summarizes Equity Award activity for the six months ended June 30, 2025:
Number of
Options 		Number of
Restricted
Stock Units		Number of
Performance
Restricted
Stock Units
Balances as of December 31, 20243,1817,8456,272
Granted(1)—3,3003,544
Vested—(2,373)—
Exercised(160)——
Forfeited, canceled or expired(1)(1)(1,426)(2,861)
Balances as of June 30, 20253,0207,3466,955
______________________________________
(1)Includes 0.9 million RSUs and 1.9 million PRSUs that were granted and canceled during the same period. Subsequent to the original grant date, we identified an inadvertent error related to the number of RSUs and PRSUs granted. The original awards were canceled and concurrently replaced with a corrected lower number of RSUs and PRSUs. The cancellation and concurrent replacement is accounted for as the modification of an award. The fair value of the replacement awards did not exceed that of the original awards for the thirteen impacted individuals, and therefore, no incremental compensation cost was recognized.

The weighted-average grant date fair value of RSUs granted during the six months ended June 30, 2025, was $5.81.
During the six months ended June 30, 2025, we granted PRSUs that have vesting conditions that are based not only on the employee’s service period but also on either revenue, Adjusted EBITDA, or Total Shareholder Return (“TSR”) through 2027. The PRSUs will vest, if at all, upon our achieving a specified target for each vesting condition. TSR will be
measured against the total shareholder return of the S&P SmallCap 600 Index during the performance period. The actual number of shares of common stock to be issued to each award recipient at the end of the performance period will be interpolated between a threshold and maximum payout amount based on actual performance results, except for two special performance goals. A participant will earn 50% of the target number of PRSUs for “Threshold Performance,” 100% of the target number of PRSUs for “Target Performance,” and 200% of the target number of PRSUs for “Base Maximum Performance.” In addition, participants may earn 350% or 500% of the target number of PRSUs upon achievement of truly exceptional Adjusted EBITDA or TSR outperformance compared to performance goals.
The weighted average grant-date fair value of PRSUs granted during the six months ended June 30, 2025, was $11.21. We estimate the grant-date fair value of TSR PRSUs using the Monte Carlo simulation model, as the TSR metric is considered a market condition under ASC Topic 718, Compensation - stock compensation.